Xiaoling Zhang
Guilin, 541199, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation.
Journal: Cancer cell international
Published: January 24, 2025
Equilibrative nucleoside transporter 3 promotes the progression of hepatocellular carcinoma by regulating the AKT/mTOR signaling pathway.
Journal: International journal of biological macromolecules
Published: January 06, 2023
Aloe-emodin targets multiple signaling pathways by blocking ubiquitin-mediated degradation of DUSP1 in nasopharyngeal carcinoma cells.
Journal: Phytotherapy research : PTR
Published: August 23, 2022
Pathogenesis and Diagnostic Significance of EBV-miR-BARTs in Nasopharyngeal Carcinoma.
Journal: Oxidative medicine and cellular longevity
Published: July 15, 2022
CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 28, 2021
Immune function changes of the IDPN-induced Tourette syndrome rat model.
Journal: International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
Published: September 04, 2020
Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
Journal: Cell biochemistry and function
Published: April 20, 2020
Loss of AKR1C1 is a good prognostic factor in advanced NPC cases and increases chemosensitivity to cisplatin in NPC cells.
Journal: Journal of cellular and molecular medicine
Published: October 11, 2019
Sarcomatoid Chromophobe Renal Cell Carcinoma: A Case Report and Review of the Literature.
Journal: The American journal of case reports
Published: August 20, 2019
F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model.
Journal: Cancer management and research
Published: April 06, 2019
Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC.
Journal: Cancer management and research
Published: March 01, 2019
Last Updated: 09/26/2026